Personalising bowel cancer detection

Sibel Saya and Professor Jon Emery

PhD Candidate, Primary Care Cancer Research Group; Herman Professor of Primary Care Cancer Research, University of Melbourne

Read more

Genomic testing can be used to recommend the type and timing of bowel cancer screening, but would people want to take a test predicting their personalised risk? A person’s bowel cancer risk can be affected by family history, inheritance of low-risk common genomic factors or rare high-risk genetic changes and environmental or lifestyle factors including ...

Already a member?

Login to keep reading.

© 2021 the limbic